Exchange Traded Concepts’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.9M Buy
110,965
+21,162
+24% +$7.85M 0.2% 91
2026
Q1
$26.3M Buy
89,803
+37,508
+72% +$12.3M 0.19% 112
2025
Q4
$18.3M Buy
52,295
+19,339
+59% +$6.54M 0.14% 161
2025
Q3
$10.6M Buy
32,956
+16,371
+99% +$5.09M 0.09% 232
2025
Q2
$6.45M Buy
16,585
+7,792
+89% +$3.13M 0.08% 259
2025
Q1
$3.82M Buy
8,793
+6,450
+275% +$2.59M 0.07% 247
2024
Q4
$864K Buy
2,343
+373
+19% +$156K 0.02% 621
2024
Q3
$1.02M Buy
1,970
+664
+51% +$355K 0.02% 498
2024
Q2
$708K Buy
1,306
+60
+5% +$31.7K 0.02% 562
2024
Q1
$646K Sell
1,246
-64
-5% -$31.8K 0.02% 576
2023
Q4
$618K Buy
1,310
+1
+0.1% +$462 0.02% 540
2023
Q3
$570K Sell
1,309
-25
-2% -$11.3K 0.02% 547
2023
Q2
$593K Sell
1,334
-1,121
-46% -$517K 0.01% 544
2023
Q1
$1.13M Buy
2,455
+1,519
+162% +$723K 0.03% 307
2022
Q4
$480K Sell
936
-196
-17% -$99.5K 0.01% 531
2022
Q3
$514K Sell
1,132
-1,260
-53% -$603K 0.02% 471
2022
Q2
$1.15M Sell
2,392
-185
-7% -$91.5K 0.03% 264
2022
Q1
$1.27M Buy
2,577
+2,303
+841% +$1.05M 0.03% 300
2021
Q4
$127K Sell
274
-668
-71% -$281K ﹤0.01% 826
2021
Q3
$351K Buy
942
+251
+36% +$95.4K 0.01% 702
2021
Q2
$264K Buy
+691
New +$264K 0.01% 724
2021
Q1
Sell
-620
Closed -$199K 1072
2020
Q4
$199K Buy
+620
New +$190K 0.01% 637
2020
Q2
Sell
-2
Closed 793
2020
Q1
$0 Hold
2
﹤0.01% 554
2019
Q4
$1K Buy
+2
New +$550 ﹤0.01% 446

Other funds holding ELV

Exchange Traded Concepts's ELV Position: Q2 2026 in Review

Exchange Traded Concepts increased its Elevance Health (ELV) stake by 24% in Q2 2026, buying an estimated $7.85M and bringing the position to 110,965 shares worth $42.9M. The position accounts for 0.2% of the portfolio, ranked #91.

Exchange Traded Concepts first reported a position in ELV in Q4 2019 and has held it in 24 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Exchange Traded Concepts held 110,965 shares of Elevance Health worth $42.9M as of Q2 2026.
  • Exchange Traded Concepts bought 21,162 Elevance Health shares in Q2 2026, an estimated $7.85M.
  • Elevance Health made up 0.2% of Exchange Traded Concepts's portfolio in Q2 2026, its #91 holding.
  • Exchange Traded Concepts first reported a position in Elevance Health in Q4 2019 and has held it in 24 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.